Prostate cancer is the most common noncutaneous cancer in men. Androgen-deprivation therapy with gonadotropin-releasing hormone (GnRH) agonists and antagonists is the cornerstone of medical management ...

Researchers have made an important discovery about how prostate cancer may start to develop. A new study reveals that the prostate as a whole, including cells that appear normal, is different in men ...

Phase II trial of everolimus monotherapy in the palliative treatment of patients with metastatic transitional cell carcinoma (TCC) after failure of platinum-based therapy: Activity and biomarkers. A ...